WEDBUSH SECURITIES INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 19 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,255,000
+34.2%
30,0000.0%0.18%
+38.6%
Q2 2022$2,426,000
-13.6%
30,0000.0%0.13%
+3.1%
Q1 2022$2,807,000
+6.9%
30,0000.0%0.13%
+13.3%
Q4 2021$2,627,00030,0000.11%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Antara Capital LP 49,500,000$47,535,0001.45%
ZAZOVE ASSOCIATES LLC 16,238,000$15,254,0001.34%
Kohlberg Kravis Roberts & Co. L.P. 26,000,000$24,456,0000.22%
WEDBUSH SECURITIES INC 30,000$2,807,0000.13%
AVIVA PLC 15,000,000$14,034,0000.07%
Context Capital Management, LLC 1,000$951,0000.06%
LMR Partners LLP 4,500,000$4,242,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 15,500,000$14,580,0000.04%
LAZARD ASSET MANAGEMENT LLC 27,770,000$26,121,0000.03%
FRANKLIN RESOURCES INC 48,000,000$45,150,0000.02%
View complete list of REVANCE THERAPEUTICS INC shareholders